The oncology drug market in China is poised to grow at a CAGR of around 13.3% over the analysis period of 2021 to 2027, according to data and analytics company StrategyHelix.
This 2nd edition of Oncology Drug Market in China includes following information:
Market Overview: Market Size, Grow Rate, CAGR
Type: Targeted Therapy Drug, Immunotherapy Drug, Chemotherapy Drug
Years Considered: this database covers the period 2016-2027
After you have placed your order and your payment has been authorized, the database download link will be emailed to you instantly. Please note that the database is supplied in an Excel spreadsheet.
StrategyHelix’ data is protected by copyright and cannot be supplied to any third party.
StrategyHelix DataPass produces a series of directories and databases on industries, economies and consumers in Western and Central Europe, North and South America, Asia Pacific, the Middle East and Africa. DataPass aims at helping our clients analyze market context and identify future trends.